This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
. Page versions: R5 R4B
| Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
General example
{
"resourceType": "MedicinalProductDefinition",
"id": "example",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>id</b>: example</p><p><b>identifier</b>: id: {mpid}</p><p><b>classification</b>: <span>B01AF02</span></p><p><b>attachedDocument</b>: <a>Generated Summary: id: example; id: urn:oid:1.3.6.1.4.1.21367.2005.3.7.1234; status: current; docStatus: preliminary; <span>Outpatient Note</span>; <span>History and Physical</span>; <span>Arm</span>; <span>Outpatient</span>; <span>General Medicine</span>; period: 23/12/2004 8:00:00 AM --> 23/12/2004 8:01:00 AM; date: 24/12/2005 9:43:41 AM; description: Physical; <span>very restricted</span></a></p><p><b>masterFile</b>: <a>Generated Summary: id: example; id: urn:oid:1.3.6.1.4.1.21367.2005.3.7.1234; status: current; docStatus: preliminary; <span>Outpatient Note</span>; <span>History and Physical</span>; <span>Arm</span>; <span>Outpatient</span>; <span>General Medicine</span>; period: 23/12/2004 8:00:00 AM --> 23/12/2004 8:01:00 AM; date: 24/12/2005 9:43:41 AM; description: Physical; <span>very restricted</span></a></p><blockquote><p><b>name</b></p><p><b>productName</b>: Equilidem 2.5 mg film-coated tablets</p><blockquote><p><b>namePart</b></p><p><b>part</b>: Equilidem</p><p><b>type</b>: <span>INV</span></p></blockquote><blockquote><p><b>namePart</b></p><p><b>part</b>: 2.5 mg</p><p><b>type</b>: <span>STR</span></p></blockquote><blockquote><p><b>namePart</b></p><p><b>part</b>: film-coated tablets</p><p><b>type</b>: <span>FRM</span></p></blockquote><h3>CountryLanguages</h3><table><tr><td>-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td>*</td><td><span>EU</span></td><td><span>EU</span></td><td><span>EN</span></td></tr></table></blockquote><h3>ManufacturingBusinessOperations</h3><table><tr><td>-</td><td><b>Type</b></td><td><b>EffectiveDate</b></td><td><b>Authorization</b></td></tr><tr><td>*</td><td/><td>2013-03-15 --> (ongoing)</td><td><span/></td></tr></table></div>"
},
"identifier": [
{
"system": "http://ema.europa.eu/example/MPID",
"value": "{mpid}"
}
],
"classification": [
{
"coding": [
{
"system": "http://ema.europa.eu/example/WHOAnatomicalTherapeuticChemicalATCClassificationSystem",
"code": "B01AF02"
}
]
}
],
"attachedDocument": [
{
"reference": "DocumentReference/example"
}
],
"masterFile": [
{
"reference": "DocumentReference/example"
}
],
"name": [
{
"productName": "Equilidem 2.5 mg film-coated tablets",
"namePart": [
{
"part": "Equilidem",
"type": {
"coding": [
{
"code": "INV"
}
]
}
},
{
"part": "2.5 mg",
"type": {
"coding": [
{
"code": "STR"
}
]
}
},
{
"part": "film-coated tablets",
"type": {
"coding": [
{
"code": "FRM"
}
]
}
}
],
"countryLanguage": [
{
"country": {
"coding": [
{
"system": "http://ema.europa.eu/example/countryCode",
"code": "EU"
}
]
},
"jurisdiction": {
"coding": [
{
"system": "http://ema.europa.eu/example/jurisdictionCode",
"code": "EU"
}
]
},
"language": {
"coding": [
{
"system": "http://ema.europa.eu/example/languageCode",
"code": "EN"
}
]
}
}
]
}
],
"manufacturingBusinessOperation": [
{
"type": {
"concept": {
"coding": [
{
"system": "http://ema.europa.eu/example/manufacturingOperationType",
"code": "Batchrelease"
}
]
}
},
"effectiveDate": {
"start": "2013-03-15"
},
"authorization": {
"identifier": {
"system": "http://ema.europa.eu/example/manufacturingAuthorisationReferenceNumber",
"value": "1324TZ"
}
}
}
]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.